{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"thyroid-cancer-nonmedullary-2","columns":[{"gene":"","key":"population-258c15ea231745f25c12","label":"Thyroid cancer, nonmedullary, 2","mondoId":"MONDO:0008566","onsetQualifier":null,"originColumnKey":"MONDO:0008566/OMIM:188470","originalViews":[{"key":"MONDO:0008566/OMIM:188470","label":"Thyroid cancer, nonmedullary, 2","scopeLabel":"OMIM:188470","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["0c711e51c70531eae0533b49c9364a1f6584b9ab0f9500b6f3ba9267bb290f8d","3ca8cb69b8955e58bafbee9051e65cc40a18eb66ad2bf455a95a068328fff3a3","94867b2306ae7dbfe0cce425b730ff9b51f02c7c6cecc45e317c520a8208c1a4"],"recordQualifiers":{},"scopeLabel":"OMIM:188470","sourceIds":["OMIM:188470"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-258c15ea231745f25c12"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0006731","HP:0040198","HP:0002895"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":3,"sourceGroups":{"omim":2,"published":1}},"features":[{"hpoId":"HP:0006731","label":"Follicular thyroid carcinoma","primary":true},{"hpoId":"HP:0040198","label":"Non-medullary thyroid carcinoma","primary":true},{"hpoId":"HP:0002895","label":"Papillary thyroid carcinoma","primary":true}],"ledeHtml":"Nonmedullary thyroid cancer (NMTC) comprises thyroid cancers of follicular cell origin and accounts for more than 95% of all thyroid cancer cases. NMTC is classified into 4 groups: papillary, follicular, Hurthle cell, and anaplastic. Approximately 5% of NMTC is hereditary, occurring as a minor component of a familial cancer syndrome (e.g., familial adenomatous polyposis, Carney complex, or as a primary feature (familial NMTC or FNMTC). Papillary thyroid cancer (PTC) is the most common histologic subtype of FNMTC, accounting for approximately 85% of cases. Follicular thyroid cancer (FTC) accounts for approximately 15% of NMTC and is defined by invasive features that result in infiltration of blood vessels and/or full penetration of the tumor capsule, in the absence of the nuclear alterations that characterize papillary carcinoma. FTC is rarely multifocal and usually does not metastasize to the regional lymph nodes but tends to spread via the bloodstream to the lung and bones. An important histologic variant of FTC is the oncocytic (Hurthle cell, oxyphilic) follicular carcinoma composed of eosinophilic cells replete with mitochondria. Susceptibility to nonmedullary thyroid cancer 2 (NMTC2) is conferred by heterozygous mutation in the SRGAP1 gene. NMTC2 follows an autosomal dominant pattern of inheritance.","mondoId":"MONDO:0008566","node":{"canonicalSlug":"thyroid-cancer-nonmedullary-2","comparisons":[{"documentSha256":"1cfda7808591b77cbc4c07c83dbff8e1dc0b1d3590e55205ddb8c240f4fb789e","key":"legacy-thyroid-tumor","kind":"legacy","label":"thyroid tumor","memberIds":["MONDO:0006468","MONDO:0008566","MONDO:0008567","MONDO:0011578","MONDO:0011653","MONDO:0014681","MONDO:0014682","MONDO:0015074","MONDO:0015277","MONDO:0017895","MONDO:0019962"],"mondoId":"MONDO:0015074","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/thyroid-tumor.1cfda7808591b77cbc4c07c83dbff8e1dc0b1d3590e55205ddb8c240f4fb789e.json"},{"documentSha256":"866dec3b944e19fd9ee6f5f7499ee18495fe9c6bd2db4ec84e445cb237d228e1","key":"expanded-thyroid-tumor","kind":"expanded","label":"thyroid tumor","memberIds":["MONDO:0002821","MONDO:0003027","MONDO:0003028","MONDO:0003701","MONDO:0003806","MONDO:0003836","MONDO:0003837","MONDO:0004101","MONDO:0004102","MONDO:0004103","MONDO:0004460","MONDO:0004483","MONDO:0004524","MONDO:0004558","MONDO:0005032","MONDO:0005034","MONDO:0005075","MONDO:0006107","MONDO:0006462","MONDO:0006463","MONDO:0006466","MONDO:0006467","MONDO:0006468","MONDO:0006886","MONDO:0007958","MONDO:0008082","MONDO:0008234","MONDO:0008565","MONDO:0008566","MONDO:0008567","MONDO:0011312","MONDO:0011368","MONDO:0011578","MONDO:0011653","MONDO:0011836","MONDO:0014681","MONDO:0014682","MONDO:0015074","MONDO:0015075","MONDO:0015277","MONDO:0015447","MONDO:0017895","MONDO:0017896","MONDO:0019003","MONDO:0019611","MONDO:0019962","MONDO:0024622","MONDO:0971033","MONDO:0971034","MONDO:0971035","MONDO:0971036"],"mondoId":"MONDO:0015074","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-866dec3b944e19fd9ee6.866dec3b944e19fd9ee6f5f7499ee18495fe9c6bd2db4ec84e445cb237d228e1.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Thyroid cancer, nonmedullary, 2","originalSourceId":"OMIM:188470","paragraphs":["Nonmedullary thyroid cancer (NMTC) comprises thyroid cancers of follicular cell origin and accounts for more than 95% of all thyroid cancer cases. NMTC is classified into 4 groups: papillary, follicular, Hurthle cell, and anaplastic. Approximately 5% of NMTC is hereditary, occurring as a minor component of a familial cancer syndrome (e.g., familial adenomatous polyposis, Carney complex, or as a primary feature (familial NMTC or FNMTC). Papillary thyroid cancer (PTC) is the most common histologic subtype of FNMTC, accounting for approximately 85% of cases. Follicular thyroid cancer (FTC) accounts for approximately 15% of NMTC and is defined by invasive features that result in infiltration of blood vessels and/or full penetration of the tumor capsule, in the absence of the nuclear alterations that characterize papillary carcinoma. FTC is rarely multifocal and usually does not metastasize to the regional lymph nodes but tends to spread via the bloodstream to the lung and bones. An important histologic variant of FTC is the oncocytic (Hurthle cell, oxyphilic) follicular carcinoma composed of eosinophilic cells replete with mitochondria. Susceptibility to nonmedullary thyroid cancer 2 (NMTC2) is conferred by heterozygous mutation in the SRGAP1 gene. NMTC2 follows an autosomal dominant pattern of inheritance."],"rawAttribution":"OMIM:188470","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:39:24Z","upstream":"OMIM:188470","url":"https://rarediseases.info.nih.gov/diseases/5206"},"ownColumnKeys":["population-258c15ea231745f25c12"],"publication":"published","relationships":[{"kind":"parent","label":"thyroid gland follicular carcinoma","mondoId":"MONDO:0005034","slug":"thyroid-gland-follicular-carcinoma"},{"kind":"parent","label":"familial papillary or follicular thyroid carcinoma","mondoId":"MONDO:0017895","slug":"familial-papillary-or-follicular-thyroid-carcinoma"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"0c711e51c70531eae0533b49c9364a1f6584b9ab0f9500b6f3ba9267bb290f8d","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:188470","disease_name":"Thyroid cancer, nonmedullary, 2","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0040198","is_excluded":false,"label":"Non-medullary thyroid carcinoma","onset_id":null,"reference":"OMIM:188470","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"3ca8cb69b8955e58bafbee9051e65cc40a18eb66ad2bf455a95a068328fff3a3","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:188470","disease_name":"Thyroid cancer, nonmedullary, 2","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002895","is_excluded":false,"label":"Papillary thyroid carcinoma","onset_id":null,"reference":"PMID:23539728","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"94867b2306ae7dbfe0cce425b730ff9b51f02c7c6cecc45e317c520a8208c1a4","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:188470","disease_name":"Thyroid cancer, nonmedullary, 2","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0006731","is_excluded":false,"label":"Follicular thyroid carcinoma","onset_id":null,"reference":"OMIM:188470","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/5206\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>OMIM:188470</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Nonmedullary thyroid cancer (NMTC) comprises thyroid cancers of follicular cell origin and accounts for more than 95% of all thyroid cancer cases. NMTC is classified into 4 groups: papillary, follicular, Hurthle cell, and anaplastic. Approximately 5% of NMTC is hereditary, occurring as a minor component of a familial cancer syndrome (e.g., familial adenomatous polyposis, Carney complex, or as a primary feature (familial NMTC or FNMTC). Papillary thyroid cancer (PTC) is the most common histologic subtype of FNMTC, accounting for approximately 85% of cases. Follicular thyroid cancer (FTC) accounts for approximately 15% of NMTC and is defined by invasive features that result in infiltration of blood vessels and/or full penetration of the tumor capsule, in the absence of the nuclear alterations that characterize papillary carcinoma. FTC is rarely multifocal and usually does not metastasize to the regional lymph nodes but tends to spread via the bloodstream to the lung and bones. An important histologic variant of FTC is the oncocytic (Hurthle cell, oxyphilic) follicular carcinoma composed of eosinophilic cells replete with mitochondria. Susceptibility to nonmedullary thyroid cancer 2 (NMTC2) is conferred by heterozygous mutation in the SRGAP1 gene. NMTC2 follows an autosomal dominant pattern of inheritance.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/5206\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"thyroid-cancer-nonmedullary-2","sourceDocuments":[{"name":"GARD: Thyroid cancer, nonmedullary, 2","reviewed":null,"source_release":"2026-10-25T03:39:24Z","url":"https://rarediseases.info.nih.gov/diseases/5206"}],"sourceNote":"","synonyms":["FTC","NMTC2","thyroid cancer, follicular","thyroid cancer, nonmedullary, 2","thyroid cancer, nonmedullary, 2, autosomal dominant, somatic mutation","thyroid cancer, nonmedullary, type 2","thyroid carcinoma, follicular","thyroid carcinoma, follicular, autosomal dominant, somatic mutation","thyroid carcinoma, follicular, somatic"],"takeawayHtml":"","title":"thyroid cancer, nonmedullary, 2"},"schemaVersion":1}
